These anti-TNF drugs are effective at inducing symptom relief, disease remission, and mucosal healing in IBD patients.[40,41] They have also been reported to reduce the need for surgery and hospitalizations among patients with moderate-to-severe IBD and contribute to better disease control with a reduction in (late) complications of the disease and improved quality of life.[42]. This evidence concerns the gene TNF and inflammatory bowel disease.